The use of biological variables to predict outcome in multiple myeloma

被引：14

作者：

Davies, FE ^{[1
]}

Jack, AS ^{[1
]}

Morgan, GJ ^{[1
]}

机构：

[1] Gen Infirm, Dept Haematol, Leeds LS1 3EX, W Yorkshire, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 1997年 / 99卷 / 04期

关键词：

multiple myeloma; prognosis; biological variables;

D O I：

10.1046/j.1365-2141.1997.3793193.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：719 / 725

页数：7

共 71 条

[31] Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma [J].

Kyrtsonis, MC ;

Dedoussis, G ;

Zervas, C ;

Perifanis, V ;

Baxevanis, C ;

Stamatelou, M ;

Maniatis, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (02) :398-400

[32] RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER TRIAL OF CLODRONATE IN MULTIPLE-MYELOMA [J].

LAHTINEN, R ;

LAAKSO, M ;

PALVA, I ;

VIRKKUNEN, P ;

ELOMAA, I .

LANCET, 1992, 340 (8827) :1049-1052

[33] IMPROVED CYTOGENETICS IN MULTIPLE-MYELOMA - A STUDY OF 151 PATIENTS INCLUDING 117 PATIENTS AT DIAGNOSIS [J].

LAI, JL ;

ZANDECKI, M ;

MARY, JY ;

BERNARDI, F ;

IZYDORCZYK, V ;

FLACTIF, M ;

MOREL, P ;

JOUET, JP ;

BAUTERS, F ;

FACON, T .

BLOOD, 1995, 85 (09) :2490-2497

[34]

Lecouvet F, 1996, BRIT J HAEMATOL, V93, P1137

[35]

LIANG W, 1979, CANCER, V44, P630

[36]

LOKHORST HM, 1994, BLOOD, V84, P2269

[37] MECHANISMS OF DISEASE - BONE-MARROW, CYTOKINES, AND BONE REMODELING - EMERGING INSIGHTS INTO THE PATHOPHYSIOLOGY OF OSTEOPOROSIS [J].

MANOLAGAS, SC ;

JILKA, RL .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (05) :305-311

[38] ACUTE PHASE PROTEINS AND PROGNOSIS IN MULTIPLE-MYELOMA [J].

MERLINI, G ;

PERFETTI, V ;

GOBBI, PG ;

QUAGLINI, S ;

FRANCIOTTA, DM ;

MARINONE, G ;

ASCARI, E .

BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (04) :595-601

[39]

NERI A, 1993, BLOOD, V81, P128

[40]

ONG F, 1995, LEUKEMIA, V9, P1282

← 1 2 3 4 5 6 7 8 →